Trace Bio Analytics brings powerful intellectual property and top academic credentials to the vast and rapidly growing field of trace analysis by mass spectrometry. Indications of the promise of our technology include the following: we are selling a unique test to Pfizer for use in drug development as part of a pilot program that continues to expand, and we have a novel, patent-protected device for sample preparation in mass spectrometry that has been awarded STTR phase I and II grants.
Connect with Trace Bio Analytics
